Anti-Hu-Associated Encephalomyelitis as a Presentation of Primary Extrapulmonary Small Cell Carcinoma of the Small Bowel: A Case Report

Small cell carcinoma (SCC) is a neuroendocrine tumor (NET) commonly found in the lung, known for rapid proliferation and early metastasis. Extrapulmonary small cell carcinomas (ESCC) are rare, with GI tract carcinomas exceedingly so. Due to the lack of clinical data on the treatment of ESCC, the standard regimen is the same as the SCC of the lung. Documented accounts of paraneoplastic encephalomyelitis associated with NETs are also uncommon. We present a patient who suffered from neurologic deficits before being diagnosed with paraneoplastic encephalomyelitis from a duodenal ESCC. The patient presented with ear pain and hematemesis. New symptoms arose after the resolution of initial symptoms, including shortness of breath and numbness. Autoimmune workup was positive for anti-Hu antibodies. A position emission tomography (PET) scan showed increased uptake in the duodenal region. Biopsy results from a duodenal ulcer revealed poorly differentiated neuroendocrine carcinoma with positive synaptophysin and strong positivity of Ki-67, consistent with ESCC. Numerous treatments, including platinum-based chemotherapy, yielded no neurologic improvement for the patient. This case details an atypical presentation of ESCC, which should be considered in patients suspected of paraneoplastic encephalomyelitis.

[1]  D. Singhal,et al.  Current Oncologic Standards for Surgery of Small Bowel Cancers , 2021, Journal of Gastrointestinal Cancer.

[2]  Raul S. Gonzalez Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms. , 2020, Surgical pathology clinics.

[3]  C. Chandrasekharan Medical Management of Gastroenteropancreatic Neuroendocrine Tumors. , 2020, Surgical oncology clinics of North America.

[4]  Peter Schirmacher,et al.  The 2019 WHO classification of tumours of the digestive system , 2019, Histopathology.

[5]  S. Bhat,et al.  Neuroendocrine Carcinoma of Duodenum—an Uncommon Tumour at an Unusual Site , 2018, Indian Journal of Surgical Oncology.

[6]  T. Takayama,et al.  [Two Cases of Neuroendocrine Carcinoma of the Non-Ampullary Duodenum]. , 2018, Gan to kagaku ryoho. Cancer & chemotherapy.

[7]  S. Sahebally,et al.  Extra‐pulmonary primary small‐cell neuroendocrine carcinoma arising from the duodenum: rare tumor, unusual location , 2017, Clinical Case Reports.

[8]  N. Hiraoka,et al.  Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature , 2017, Langenbeck's Archives of Surgery.

[9]  T. Fitzgerald,et al.  Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease? , 2015, Surgery.

[10]  W. D. de Herder,et al.  Two patients with a neuroendocrine tumour of the small intestine and paraneoplastic myasthenia gravis , 2014, Endocrinology, diabetes & metabolism case reports.

[11]  V. Adam,et al.  Paraneoplastic limbic encephalitis in a patient with adenocarcinoma of the colon: a case report. , 2013, Journal of clinical anesthesia.

[12]  Mercedes F. Paredes,et al.  Neurological manifestation of colonic adenocarcinoma , 2012, Rare tumors.

[13]  E. Matano,et al.  Paraneoplastic Sensitive Neuropathy Associated with Anti-Hu Antibodies in a Neuroendocrine Tumor of Duodenum: A Case Report , 2010, International journal of immunopathology and pharmacology.

[14]  B. Johnson Management of small cell lung cancer. , 1999, Clinics in chest medicine.

[15]  Martin A. Samuels,et al.  ADAMS AND VICTOR'S PRINCIPLES OF NEUROLOGY , 2010, Neurology.

[16]  M. Wick,et al.  Primary duodenal small-cell neuroendocrine carcinoma with production of vasoactive intestinal polypeptide. , 1986, Archives of pathology & laboratory medicine.